Disease-Management-Programs in the Field of Diabetes Mellitus with Identification of the Best Practice in Europe: A Scoping Review

Abstract

The objective of this scoping review was to create an up-to-date descriptive overview of published Disease-Management-Program evaluations conducted within Europe. We also assessed the methodological quality of the evaluation and the comparability of the included studies. The Databases Pub Med via Medline and Embase via Ovid were searched for thematically fitting publications. Out of 649 initial titles and abstracts, 45 full-texts were screened for inclusions. Finally, 21 publications met all inclusion criteria. DMPs from Germany, Austria, Italy, the Netherlands and Great Britain were included. The results are tabulated in the results section and discussed descriptively. Due to the heterogeneity of the included studies and the application of sometimes potentially biased study design comparisons were difficult. A uniform European-wide evaluation strategy and common quality features would be desirable.

Key words

disease management - HbA1c - diabetes care - Diabetes mellitus type 2 - chronic care

• References

• 1 Euronews. Wo in Europa ist Diabetes am weitesten verbreitet? (14.11.2017). Im Internet https://de.euronews.com/2014/11/14/wo-in-europa-ist-diabetes-am-weitesten-verbreitet Accessed: 14.02.2019
• 2 Rothe U. Zur Effektivität und Effizienz integrierter Versorgungskonzepte am Beispiel des Sächsischen Diabetes-Management-Programmes (Sächsisches Betreuungsmodell). Ein Beitrag zur Versorgungsforschung. Düren: Shaker Verlag; 2010
• 3 Wang J. Untersuchung der Versorgungsqualität von Typ-2-Diabetikern Sachsens an einer zufällig ausgewählten Stichprobe im Rahmen des Sächsischen integrierten Betreuungsmodells bei 3.Sächsischen Diabetesvereinbarungen [Magisterarbeit]. Dresden, Sachsen: Technische Universität Dresden, Medizinische Fakultät Carl Gustav Carus. 2007
• 4 Hunter D, Fairfield G. Disease Management. BMJ 1997; 315: 50-53
• 5 Rothe U. Die neue Generation des DMP - Chronic Care Management in einem wertorientierten Gesundheitssystem. Diabetes aktuell 2013; 11: 127-131
• 6 Rothe U, Manuwald U, Kugler J. et al. Quality criteria/key components for high quality of diabetes management to avoid diabetes-related complications. J Pub Health.
• 7 Moher D, Liberati A, Tetzlaff A. et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA Statement. PLoS Medicine 2009; 6: e1000097
• 8 Flamm M, Panisch S, Winkler H. et al. Effectiveness of the Austrian disease management programme "Therapie Aktiv" for type 2 diabetes regarding the improvement of metabolic control, risk profile and guideline adherence: 2 years of follow up. Wien Klin Wochenschr 2012; 124: 639-646
• 9 Sönnichsen A, Winkler H, Flamm M. et al. The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial. BMC Fam Pract 2010; 11: 86
• 10 Rothe U, Muller G, Schwarz P. et al. Evaluation of a diabetes management system based on practice guidelines, intergrated care, and continuous quality management in a Federal State of Germany: A population-based approach to health care research. Diabetes Care 2008; 31: 863-868
• 11 Stark RG, Schunk MV, Meisinger C. et al. Medical care of type 2 diabetes in German Disease Management Programmes: a population-based evaluation. Diabetes Metab Res Rev 2011; 27: 383-391
• 12 Kostev K, Rockel T, Jacob L. Impact of disease management programes on HbA1c values in type 2 diabetes patients in Germany. J Diabetes Sci Technol 2017; 11: 117-122
• 13 Mehring M, Donnachie E, Bonke FC. et al. Disease management programs for patients with type 2 diabetes mellitus in Germany: a longitudinal population-based descriptive study. Diabetol Metab Syndr 2017; 9: 37
• 14 Wiefarn S, Kostev K, Heumann C. et al. [Effect of the Disease Management Program on HbA1c Value in Type 2 Diabetes Mellitus Patients: A Retrospective Comparison between Disease Management Programs and Standard Care]. Dtsch Med Wochenschr 2017; 142: e148-e155
• 15 Drabik A, Büscher G, Sawicki P. et al. Life prolonging of disease management programes in patients with type 2 diabetes ist cost-effective. Diabetes Res Clin Pract 2012; 95: 194-200
• 16 Drabik A, Büscher G, Thomas K. et al. Patients with type 2 diabetes benefit from primary care-based disease mangement: A propensity score matched survival time analysis. Popul Health Manag 2012; 15: 241-247
• 17 Drabik A, Graf C, Büscher G. et al. [Evaluating the effectiveness of a disease management program diabetes in the German Statutory Health Insurance: first results and methodological considerations]. Z Evid Fortbild Qual Gesundhwes 2012; 106: 649-655
• 18 Berthold H, Bestehorn K, Jannowitz C. et al. Disease management programs in type 2 diabetes: quality of care. Am J Manag Care 2011; 17: 393-403
• 19 Miksch A, Laux G, Ose D. et al. Is there a survival benefit within a German primary care-based disease management program?. Am J Manag Care 2010; 16: 49-54
• 20 Stock S, Drabik A, Buscher G. et al. German Diabetes Management Programs Improve Quality Of Care And Curb Costs. Health Aff (Millwood) 2010; 29: 2197-2205
• 21 Schulze J, Rothe U, Müller G. et al. Verbesserung der Versorgung von Diabetikern durch das sächsische Betreuungsmodell. Dtsch Med Wochenschr 2003; 128: 1161-1166
• 22 Piehlmeier W, Renner R, Fahn J. et al. Ten years experience with the disease management programme PROSIT for diabetes. Diabetes Res Clin Pract 2006; 74: S205-S209
• 23 Riedl R, Robausch M, Berghold A. The Evaluation of the Effectiveness of Austrians Disease Management Program in Patients with Type 2 Diabetes Mellitus – A Population-Based Retrospective Cohort Study. PLoS One 2016; 11: e0161429
• 24 Ostermann H, Hoess V, Mueller M. Efficiency of the Austrian disease management program for diabetes mellitus type 2: a historic cohort study based on health insurance provider’s routine data. BMC Pub Health 2012; 12: 490
• 25 Colucci A, Bianco A, Pomara F. et al. Disease management of type 2 diabetes: a follow-up analysis in a sanitary district of Sicily. Minerva Gastroenterol Dietol 2011; 57: 241-246
• 26 Elissen A, Duimel-Peeters I, Spreeuwenberg C. et al. Toward tailored disease management for type 2 diabetes. Am J Manag Care 2012; 18: 619-630
• 27 Choudhury S, Hussain S, Yao G. et al. The Impact of a Disease Local Enhanced Service on Quality Outcome Framework Diabetes Outcomes. PLoS One 2013; 8: e83738
• 28 Luzio S, Piehlmeier W, Tovar C. et al. Results of the pilot study of DIADEM – A comprehensive disease management programme for type 2 diabetes. Diabetes Res Clin Pract 2007; 76: 410-417
• 29 Steiermärkische Betriebskrankenkasse. Therapie Aktiv- Diabetes im Griff (01.09.2017). http://diabetes.therapie aktiv.at/portal27/diabetesportal/ content?contentid=10007.682250&viewmode=content&portal:componentId=gtn5038fdc3-0cfe-4dda-9da1-c0133999aa15; Accessed: 01.04.2018
• 30 Epicentro. Integrazione, gestione e assistenza- The IGEA Project. Im Internet https://www.epicentro.iss.it/igea/en/project Accessed: 29.06.2019
• 31 Struijs JN/ National Institute of Public Health and the Environment (RIVM). Integrating care by bundled payments in the Netherlands. http://www.rivm.nl/en/Documents_and_publications/Scientific/Reports/2012/november/Effects_of_bundled_payment_on_curative_health_care_costs_in_the_Netherlands_An_analysis_for_diabetes_care_and_vascular_risk_management_based_on_nationwide_claim_data_2007_2010 Accessed: 25.09.2017
• 32 Maggini M. IGEA – a chronic disease management project for people with diabetes. Ann Ist Super Sanita 2009; 45: 349-352
• 33 Regierungsprogramm für die XXIV. Gesetzgebungsperiode. Im Internet http://oktogon.at/HDG/Regierungsprogramm_2008_2013.pdf Stand: 29.06.2019
• 34 Mohnen SM, Baan CA, Struijs JN. Anwendung neuer Vergütungsformen im Rahmen niederländischer DMP: Auswirkungen auf Prozessqualität und Kosten. Pub Health Forum 2013; 21: 8-10
• 35 NHS Digital. Quality and Outcomes Framework. QOF 2015/16 results. https://qof.digital.nhs.uk/ Accessed: 05.10.2017
• 36 Drabik A, Sawicki P, Müller D. et al. Die Methoden der Evaluation von Disease Management Programmen im Kontrollgruppendesign am Beispiel Diabetes mellitus - Eine systematische Übersicht. Gesundheitswesen 2012; 74: 496-501
• 37 Fuchs S, Henschke C, Blümel M. et al. Disease management programs for type 2 diabetes in Germany. Dtsch Arztebl Int 2014; 111: 453-463
• 38 Wagner E, Austin B, Von Korff M. Organizing care for patients with chronic illness. Milbank Q 1996; 74: 511-544